Immunoregulation of malarial infection: Balancing the vices and virtues

International Journal for Parasitology

Volumn 28, Issue 1, 1998, Pages 135-148

  Taylor Robinson, Andrew W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

As exual stages; Cytokines; Immunoregulation; Malaria; Pathology; Plasmodium; Protection; Th1; Th2

Indexed keywords

MALARIA VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; CONFERENCE PAPER; HOST RESISTANCE; IMMUNOPROPHYLAXIS; IMMUNOREGULATION; LIFE CYCLE; MALARIA; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE SUSCEPTIBILITY; HUMANS; LIFE CYCLE STAGES; MACROPHAGE ACTIVATION; MALARIA; MICE; MORBIDITY; MORTALITY; PLASMODIUM; T-LYMPHOCYTES; TROPICAL CLIMATE;

EID: 0031941178     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(97)00173-2     Document Type: Conference Paper

References (93)

1. [1] McGregor IA. Studies on the acquisition of immunity to Plasmodium falciparum infections in Africa. Trans R Soc Trop Hyg Med 1964; 58: 80-88.
2. [2] Long CA. Immunity to blood stages of malaria. Curr Opin Immunol 1993; 5: 548-556.
3. [3] Cox FEG. Major animal models in malaria research: rodent. In: Wernsdorfer WH, McGregor I, editors. Malaria: principles and practice of malariology. Edinburgh: Churchill Livingstone, 1988; 1503-1543.
4. [4] Stevenson MM, Lyanga JJ, Skamene E. Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect Immun 1982; 38: 80-88.
5. [5] Gilks CF, Walliker D, Newbold CI. Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi - a rodent malaria model. Parasite Immunol 1990; 12: 45-64.
6. [6] von der Weid T, Langhorne J. The roles of cytokines produced in the immune response to the erythrocytic stages of mouse malarias. Immunobiology 1993; 189: 397-418.
7. [7] Yap GS, Jacobs P, Stevenson MM. Th cell regulation of host resistance to blood-stage Plasmodium chabaudi AS. Res Immunol 1994; 145: 419-422.
8. [8] Taylor-Robinson AW. Regulation of immunity to malaria: valuable lessons learned from murine models. Parasitol Today 1995; 11: 334-341.
9. [9] Mosmann T. R, Coffman RL Two types of mouse helper T-cell clone: implications for immune regulation. Immunol Today 1987; 8: 223-227.
10. + T-cells in the immune response to Plasmodium chabaudi. Parasitol Today 1989; 5: 362-364.
11. + T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int Immunol 1989; 1: 416-424.
12. + T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi. Immunology 1992; 77: 99-105.
13. [13] Stevenson MM, Tam M-F. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin Exp Immunol 1993; 91: 77-83.
14. [14] Shear HL, Ng C, Zhao Y. Cytokine production in lethal and non-lethal murine malaria. Immunol Lett 1990; 25: 123-127.
15. [15] Slade SJ, Langhorne J. Production of interferen-γ during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 1989; 179: 353-365.
16. [16] Stevenson MM, Fong Tam M, Belosevic M, Van der Meide PH, Podoba JE. Role of endogenous γ-interferon in host response to infection with blood-stage Plasmodium chabaudi AS. Infect Immun 1990; 58: 3225-3232.
17. [17] Taylor-Robinson AW, Phillips RS. B cells are required for the switch from Th1-to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection. Infect Immun 1994; 62: 2490-2498.
18. [18] Bate CAW, Taverne J, Playfair JHL. Malarial parasites induce TNF production by macrophages. Immunology 1988; 64: 227-231.
19. [19] Stevenson MM, Ghadirian E. Human recombinant TNF-α protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection. Infect Immun 1989; 57: 3936-3939.
20. [20] Clark IA, Hunt NH, Butcher GA, Cowden WB. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant IFN-γ or TNF-α, and its enhancement by butylated hydroxyanisole. J Immunol 1987; 139: 3493-3496.
21. [21] Jacobs P, Radzioch D, Stevenson MM. A Th1-associated increase in TNF-α expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect Immun 1996; 64: 535-541.
22. [22] Stevenson MM, Tam MF, Wolf SF, Sher A. IL-12-induced protection against blood stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J Immunol 1995; 155: 2545-2556.
23. [23] Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of IFN-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158: 670-689.
24. [24] Weinberg JB, Hobbs MM, Misukonis MA. Recombinant human γ-interferon induces human monocyte polykaryon formation. Proc Natl Acad Sci USA 1984; 81: 4554-4557.
25. [25] Clark IA, Hunt NH. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun 1983; 39: 1-6.
26. [26] Dockrell HM, Playfair JHL. Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun 1983; 39: 456-459.
27. [27] Cavacini LA, Guidotti M, Parke LA, Melancon-Kaplan J, Weidanz WP. Reassessment of the role of splenic leukocyte oxidative activity and macrophage activation in expression of immunity to malaria. Infect Immun 1989; 57: 3677-3682.
28. [28] Rockett KA, Targett GAT, Playfair JHL. Killing of blood-stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum. Infect Immun 1988; 56: 3180-3183.
29. [29] Taylor-Robinson AW. Antimalarial activity of nitric oxide: cytostasis and cytotoxicity towards Plasmodium falciparum. Biochem Soc Trans 1997; 25: 262S.
30. [30] Ignarro LJ. Endotheliurn-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters. Pharmaceut Res 1989; 6: 651-659.
31. [31] Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, Liew FY. The role of Th1 and Th2 cells in a rodent malaria infection. Science 1993; 260: 1931-1934.
32. [32] Taylor-Robinson AW, Severn A, Phillips RS. Kinetics of nitric oxide production during infection and reinfection of mice with Plasmodium chabaudi. Parasite Immunol 1996; 18: 425-430.
33. [33] Jacobs P, Radzioch D, Stevenson MM. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J Immunol 1995; 155: 5306-5313.
34. [34] Anstey NM, Weinberg JB, Hassanali M, et al. Nitric oxide in Tanzanian children with malaria - inverse relationship between malaria severity and nitric oxide production and nitric oxide synthase type 2 expression. J Exp Med 1996; 184: 557-567.
35. [35] Kremsner PG, Neifer S, Chaves MF, Rudolph R, Bienzle U. IFN-γ induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine. Eur J Immunol 1992; 22: 2873-2878.
36. [36] Jarra W, Brown KN. Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and Plasmodium yoelii yoelii. Parasite Immunol 1989; 11: 1-13.
37. [37] McDonald V, Phillips RS. Plasmodium chabaudi: adoptive transfer of immunity with different spleen cell populations and development of protective activity in the serum of lethally irradiated recipient mice. Exp Parasitol 1980; 49: 26-33.
38. [38] Phillips RS. Plasmodium berghei: passive transfer of immunity by antisera and cells. Exp Parasitol 1970; 27: 479-495.
39. [39] Jarra W, Hills LA, March JC, Brown KN. Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum. Parasite Immunol 1986; 8: 239-254.
40. [40] Isakson PC, Pure E, Vitetta ES, Krammer PH. T cell-derived B-cell differentiation factor(s). Effect on the isotype switch of murine B-cells. J Exp Med 1982; 155: 734-748.
41. [41] Coffman RL, Seymour BW, Lebman DA, et al. The role of helper T-cell products in mouse B-cell differentiation and isotype regulation. Immunol Rev 1988; 102: 5-28.
42. [42] Taylor DW. Humoral immune responses in mice and man to malarial parasites. In: Stevenson MM, editor. Malaria: host responses to infection. Boca Raton, FL: CRC Press, 1989; 1-36.
43. [43] Phillips RS, Mathers KE, Taylor-Robinson AW. T cells in immunity to Plasmodium chabaudi chabaudi: operation and regulation of different pathways of protection. Res Immunol 1994; 145: 406-412.
44. [44] Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988; 140: 4245-4252.
45. [45] Rabin EM, Mond JJ, Ohara J, Paul WE. Interferon-γ inhibits the action of B-cell stimulatory factor-1 on resting B-cells. J Immunol 1986; 137: 1573-1576.
46. [46] Mamula MJ, Janeway CA. Do B cells drive the diversification of immune responses? Immunol Today 1993; 14: 151-152.
47. [47] Lanzavecchia A. Antigen-specific interactions between T and B cells. Nature 1985; 314: 537-539.
48. + T cell subsets to Plasmodium chabaudi chabaudi in B cell-deficient mice. Int Immunol 1993; 5: 1343-1348.
49. [49] Taylor-Robinson AW, Phillips RS. Reconstitution of B cell-depleted mice with B cells restores Th2-type immune responses during Plasmodium chabaudi chabaudi infection. Infect Immun 1996; 64: 366-370.
50. [50] von der Weid T, Honarvar N, Langhorne J. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J Immunol 1996; 156: 2510-2516.
51. [51] Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev 1989; 111: 79-110.
52. [52] Schmitz J, Assenmacher M, Radbruch A. Regulation of T-helper cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol 1993; 23: 191-199.
53. [53] Moore KW, O'Garra A, De Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-190.
54. [54] Parish CR. The relationship between humoral and cell-mediated immunity. Transplant Rev 1972; 13: 35-66.
55. [55] Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992; 257: 539-542.
56. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J Exp Med 1995; 182: 1579-1584.
57. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell-type. J Exp Med 1995; 181: 1081-1089.
58. [58] Taylor-Robinson AW, Liew FY, Severn A, et al. Regulation of the immune response by nitric oxide differentially produced by Th1 and Th2 cells. Eur J Immunol 1994; 24: 980-984.
59. [59] Taylor-Robinson AW. Counter-regulation of T helper 1 cell proliferation by nitric oxide and IL-2. Biochem Biophys Res Commun 1997; 233: 14-19.
60. [60] Rockett KA, Awburn MM, Rockett EJ, Cowden WB, Clark IA. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol 1994; 16: 243-249.
61. [61] Greenwood BM, Playfair JHL, Torrigiani G. Immunosuppression in murine malaria: I. General characteristics. Clin Exp Immunol 1971; 8: 67-478.
62. [62] Greenwood BM, Bradley-Moore AM, Bryceson ADM, Palit A. Immunosuppression in children with malaria. Lancet 1972; i: 169-172.
63. [63] Liew FY. Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol 1995; 7: 396-399.
64. [64] Stevenson MM, Ghadirian E. Human recombinant TNF-α protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection. Infection and Immunity 1989; 57: 3936-3939.
65. [65] Clark IA, Chaudhri G. Relationship between inflammation and immunopathology of malaria. In: Stevenson MM, editor. Malaria: host responses to infection. Boca Raton, FL: CRC Press, 1989; 127-146.
66. [66] Clark IA, Cowden WB, Butcher GA, Hunt NH. Possible roles of TNF in the pathology of malaria. Am J Pathol 1987; 129: 192-199.
67. [67] Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237: 1210-1212.
68. [68] Clark IA, MacMicking JD, Gray KM, Rockett KA, Cowden WB. Malaria mimicry with tumor necrosis factor. Am J Pathol 1992; 140: 325-336.
69. [69] von der Weid T, Kopf M, Köhler G, Langhorne J. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 1994; 24: 2285-2293.
70. [70] Linke A, Kühn R, Müller W, Honarvar N, Li C, Langhorne J. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol 1996; 84: 253-263.
71. [71] de Kossodo S, Grau GE. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 1993; 151: 4811-4820.
72. [72] Medana IM, Hunt NH, Chaudhri G. Tumor necrosis factor-α expression in the brain during fatal murine cerebral malaria. Evidence for production by microglia and astrocytes. Am J Pathology 1997; 150: 1473-1486.
73. [73] Grau GE, Pontaire P, Piguet PF, et al. Late administration of monoclonal antibody to leukocyte function antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol 1991; 21: 2265-2267.
74. [74] Rudin W, Eugster H-P, Bordmann G. Resistance to cerebral malaria in tumor necrosis factor-α/β-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol 1997; 150: 257-266.
75. [75] Chizzotini C, Grau GE, Geinoz A, Schrijvers D. T-lymphocyte interferon-γ production induced by Plasmodium falciparum antigen is high in recently infected nonimmune and low in immune subjects. Clin Exp Immunol 1990; 79: 95-99.
76. [76] Clark IA, Rockett KA, Cowden WB. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992; 340: 894-896.
77. [77] Ghigo D, Todde R, Ginsburg H, et al. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor. J Exp Med 1995; 182: 677-688.
78. [78] Asensio VC, Oshima H, Falanga PB. Plasmodium berghei: is nitric oxide involved in the pathogenesis of mouse cerebral malaria? Exp Parasitol 1993; 77: 111-117.
79. [79] Kremsner PG, Nüssler A, Neifer S, et al. Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. Immunology 1993; 78: 286-290.
80. [80] Grau GE, de Kossodo S. Cerebral malaria - mediators, mechanical obstruction or more? Parasitol Today 1994; 10: 408-409.
81. [81] Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu Rev Immunol 1993; 11: 637-685.
82. [82] Ho M, Webster HK, Tongtawe P, Pattanapanyasat K, Weidanz WP. Increased γδ T cells in acute Plasmodium falciparum malaria. Immunol Lett 1990; 25: 139-142.
83. [83] Perera MK, Carter R, Goonewardene R, Mendis KN. Transient increase in circulating γδ T cells during Plusmodium vivax malarial paroxysms. J Exp Med 1994; 179: 311-315.
84. [84] Langhorne J, Goodier M, Behr C, Dubois P. Is there a role for γβ T cells in malaria? Immunol Today 1992; 13: 298-300.
85. [85] Tsuji M, Mombaerts P, LeFrancois L, Nussenzweig RS, Zavala F, Tonegawa S. γδ T cells contribute to immunity against the liver stages in αβ T-cell-deficient mice. Proc Natl Acad Sci USA 1994; 91: 345-349.
86. [86] Langhorne J, Mombaerts P, Tonegawa S. αβ and γδ T cells in the immune response to the erythrocytic stages of malaria in mice. Int Immunol 1995; 7: 1005-1011.
87. [87] van der Hyde HC, Elloso MM, Chang W-L, Kaplan M, Manning DD, Weidanz WP. γδ T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. J Immunol 1995; 154: 3985-3990.
88. [88] Elloso MM, van der Heyde HC, van de Waa JA, Manning DD, Weidanz WP. Inhibition of Plasmodium falciparum in vitro by human γδ T cells. J Immunol 1994; 153: 1187-1191.
89. [89] Rzepczyk C, Anderson K, Stamatiou S, et al. γδ T cells: their immunobiology and role in malaria infections. Int J Parasitol 1997; 27: 191-200.
90. [90] Roberts CW, Satoskar A, Alexander J. Sex steroids, pregnancy-associated hormones and immunity to parasitic infection. Parasitol Today 1996; 12: 382-388.
91. [91] Benten WP, Wunderlich F, Herrmann R, Kuhn-Velten WN. Testosterone-induced compared with oestradiol-induced immunosuppression against Plasmodium chabaudi malaria. J Endocrinol 1993; 139: 487-494.
92. [92] Mohan PF, Jacobson MS. Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Am J Med Sci 1993; 306: 10-15.
93. [93] Chao TC, Van Alten PJ, Walter RJ. Steroid sex hormones and macrophage function - modulation of reactive oxygen intermediates and nitrite release. Am J Reprod Immunol 1994; 32: 43-52.